Dr. Lin at the JCVI outlining update of advice now in a briefing. They seem to be considering mostly direct benefits on children, and 'impacts of vaccine or other childhood vaccination programmes' like meningitis vaccination.Wish he would extrapolate- is this a capacity issue?🧵
Dr. Lin says it is rare for severe outcomes to occur. He talks about long COVID - saying this only occurs in 'a very small proportion' of long COVID. Wonder what data he bases this on, given the most unbiased and representative data suggest 8% incidence of symptoms for 12 wks.
He says vaccine benefits are greater for 'older children than younger children'. Is he referring to 16-17 yr olds vs 12-15 yr olds? Is he going to articulate what this difference is, and why vaccines aren't been extended to 12+
He is saying they are seeing several children in hospital with severe covid, requiring oxygen and ventilation.
So they're now saying 16-17 yr olds going to be offered just one dose at the moment pending updates.
They're not advising on 2nd doses at the moment suggesting there isn't enough data - possibly on dosing intervals? Unclear what data they're waiting for. >7 mil adolescents have been fully vaccinated in the US.
For 12-15 yr olds, vaccines still only offered to children with v. limited specific conditions (so not the much wider group of 16-17 yr olds and adults who were prioritised). Very unclear what evidence any of this is based on.
Now being asked why the sudden change given data has been the same for some time. They're suggesting this is based on data on myocarditis- makes no sense given they announced on 19th July, when >7 million had been vaccinated in the US alone & myocarditis risk was well understood.
He suggests it's 'more data on the summer wave'. Not sure how this would justify delaying, given infection rates were even higher at the time the decision was made. Looks like this will start in 'a very short number of weeks'. Saying supply is not a problem.
Being asked why they missed the opportunity given the very sick children being seen in hospitals and ICUs - also for 12-15 yr olds. Dr. Lin again saying only those with specific underlying conditions will be offered.
Saying the 'vast majority' of those who become unwell have underlying conditions. Where's this data? What about long COVID. This affects a lot of health children? Protecting 'the majority' who become unwell isn't sufficient, when children are being exposed to high infection risks
It seems that long COVID hasn't been considered here - do we know what proportion of long COVID is among those with these conditions? Because the data from adults certainly suggests that this is common even among those with no pre-existing conditions.
Dr. Lin talking about 'fuzziness of data' and 'certainty of separation of dots' when being asked on whether the data has changed. No clear answer- if there is greater certainty, what is this based on, given data on millions of vaccinated adolescents has been available for months?
Being asked to 'put numbers on the dots', given their advice 2 weeks ago said benefits did not clearly outweigh risks. Dr Lin again talking about 'being as sure as possible for safety'. He talks about being 'cautionary' and 'placing high value on safety of children.
I honestly find this argument bizarre, given the JCVI strategy is anything but cautionary. At a point in time when infection risk has been 1%/wk in this age group they essentially made a decision that risk of infection was less than risk of vaccination. How is that cautionary?
Dr. Lin says he is 'reluctant to put a number on it', given it's complex. That's odd - because the way we make decisions is by quantitatively weighing risks and benefits. We did this here just like the CDC did.
Their response is completely inadequate. osf.io/grzma
JVT now defending JCVI saying that we should not 'move faster than science'. No danger of that happening, given we're always behind on evidence & science. It's clear the evidence hasn't changed, and we've allowed thousands of adolescents to get infected over the past weeks.
Many of these have developed long COVID, and some have been hospitalised when they could've been vaccinated. Going slow on vaccinating children when vaccines found to be safe & effective in millions is anything but 'cautionary' and 'safe'.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Surprising to see @MAbsoud the senior author of the KCL study trying to explain the discrepancy between long COVID estimates from the very flawed Zoe KCL, and the nationally representative ONS study by critiquing the ONS without even understanding the ONS methodology.🧵
He says that ONS data are collected monthly & is retrospective so less valid. This isn't true- ONS collects data on long COVID every week for the first 5 wks & then monthly. Versus Zoe that depends on parents being motivated to report symptoms of a sick child for months.
It also assumes that symptoms resolved when parents stop reporting. How many parents would continue to report for 6 months or a year (ONS shows that sadly many children do have continuing symptoms for a year)- especially when they aren't even asked directly about common symptoms
While I'm grateful that JCVI are advising vaccinating all 16-17 yrs, this delay has been costly. We're still behind vaccine policy in other countries for 12-15 yr olds. Our preprint out today shows benefits far outweigh risks for 12-17 yr olds in England🧵 osf.io/grzma
The UK strategy is out of line with many other countries, including US, Israel, and much of Europe & SE Asia that have prioritised vaccination of all 12-17 yr olds. >9 million adolescents have been vaccinated in the US alone, and benefit vs risks have been quantified carefully.
Rather disappointed by the reporting of what is a heavily flawed study in the media to suggest that long COVID is rare in children. There are many issues with this study that I'm sure long COVID researchers & patients will flag, but here's my analysis🧵 thelancet.com/journals/lanch…
1. Let's look at the context of the study. It's proxy reporting for children by parents through the Zoe symptom tracker. The study acknowledges that those using the app are more likely to be white & higher socio-economic status, both associated with reduced risk of poor outcomes
2. Even among those sampled and found to be PCR positive, only 24% appear to have had information deemed complete enough for analysis. Are those who were deemed to have more complete information logged likely to have been different from everyone using the app? Very possibly.
The timing/extent of decline of hospitalisations suggests that the extent of decline we've seen in cases for the past 2 wks was likely real. Not sure how to square this with positivity, but hospitalisations are the real test & their extent/rate of decline tells us what happened🧵
I was more skeptical of case declines in children at the same time, because positivity had continued to rise even though cases were declining, suggesting undertesting/underreporting. But hosps in kids have peaked, which suggests these declines were real.
As many others have commented, it's likely a number of factors contributed - included the end of Euro2020s, >33% of children in secondaries being absent at the end of term, many Y11-13 being off post-exams, and many people isolating.
Strongly recommend reading this doc from SAGE on virus evolution released today. Alongside several scenarios, it assesses the risk of variants emerging that lead to 'vaccine failure' as 'almost certain' & recommends controlling transmission to avert this. This is a stark warning.
We seem to be taking the very path that will get us to this devastating outcome. Given the impact delta has already had, & in light of recent evidence from the CDC, we cannot afford any more new variants emerging - we need to take preventive action now.
And contrary to suggestions by some that SARS-CoV-2 is moving to becoming more benign (refuted by the fact that several more severe variants have already evolved and spread), it considers a move to more severe variants a 'realistic possibility'
The PHE report released yesterday shows inconsistencies between case rates in England & positivity (the proportion of tests that are positive). This together with ONS data today suggests that at least some of the steep drops in cases we're seeing are down to less testing.🧵
First, let's compare case incidence to positivity rates. Case incidence depends on overall number of positive COVID-19 cases found each week. Positivity looks at proportion of tests that were positive. Case numbers will depend on background incidence & level of testing.
Positivity can help us when tests are declining, because cases found can come down when people aren't being tested for whatever reason. But positivity should remain high. The PHE report shows sharp declines in cases, but only very recent plateauing/slight decline of positivity.